Your browser doesn't support javascript.
loading
Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation.
Ding, Kaibo; Peng, Zhongsheng; Liu, Dujiang; Xu, Yanjun.
Afiliação
  • Ding K; Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, No. 1 East Banshan Road, Gongshu District, Hangzhou, 310022, Zhejiang, China.
  • Peng Z; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China.
  • Liu D; Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, No. 1 East Banshan Road, Gongshu District, Hangzhou, 310022, Zhejiang, China.
  • Xu Y; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China.
J Transl Med ; 22(1): 761, 2024 Aug 14.
Article em En | MEDLINE | ID: mdl-39143613
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Éxons / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Adenocarcinoma de Pulmão / Afatinib / Compostos de Anilina / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Éxons / Resistencia a Medicamentos Antineoplásicos / Receptores ErbB / Adenocarcinoma de Pulmão / Afatinib / Compostos de Anilina / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2024 Tipo de documento: Article